Honey on Burns: What the Evidence Shows
Burns are among the oldest recorded uses of honey — and Dr. Ferhat Öztürk's 2024 systematic review gathered 38 studies on exactly this question. What the evidence shows, what “medical-grade” means, and how a burn dressing reaches the market.
Long before burn units existed, healers reached for honey on burned skin. Dr. Ferhat Öztürk — the biomedical scientist known as “The Honey Professor,” now Associate Professor of Biology at Sul Ross State University International — decided to test that ancient instinct the modern way: as lead author of a 2024 systematic review gathering 38 studies on honey for burn wound treatment. ghmap.io covers the field's agenda, and burn care is a revealing corner of it: a place where traditional remedies, clinical evidence, and regulated products visibly collide.
What 38 studies say
- Scope: 38 studies published between 2013 and 2024, systematically gathered and appraised in a single review — “A Systematic Review of Honey's Benefits for Burn Wound Treatment,” a 2024 book chapter in Food Science and Nutrition: Health Benefits of Honey and Propolis — Scientific Evidence and Medicinal Uses.
- Lead author: Öztürk, with co-authors Lozano, Ndayisenga, and Yilmaz.
- Reported benefits: faster recovery, reduced infection, and improved scar formation with honey in burn wound treatment.
- Context: the review sits alongside his 2025 co-authored consensus paper defining what “medical-grade” honey actually means.
From folk remedy to defined standard
Evidence alone does not make a medical product — standards do. In 2025 Öztürk co-authored “Medical-grade honey: its definition and refined standards” in the Journal of Wound Care (2025, 34(6):412–423; DOI: 10.12968/jowc.2024.0206), a consensus paper setting out organic production, gamma sterilization, clinical safety benchmarks, and physicochemical criteria. For burns this matters enormously: burned skin is highly vulnerable to infection, so sterility and defined antibacterial potency are non-negotiable. The distance between “honey helped in a trial” and “this dressing is safe for a burn ward” is exactly what the standard is built to close.
Burns in the regulatory record
Honey-based wound dressings are regulated as medical devices, cleared through the FDA's 510(k) pathway under product code FRO (“Dressing, wound, drug”). The U.S. precedent line is MEDIHONEY (Derma Sciences, now Integra LifeSciences): the calcium alginate variant (K133279, cleared June 25, 2015) carries indications that explicitly include first- and second-degree burns. A January 2025 review counted more than twenty FDA-cleared honey-based wound products. The category also carries a quality lesson from 2025: the FDA logged Class II recalls of MediHoney gel (January, a packaging defect) and MediHoney hydrogel sheet dressings (August, packaging failures risking sterile-barrier breach) — a reminder that in wound care, manufacturing quality is clinical quality.
Checklist
What “evidence-based” means for a burn product
- Systematic reviews that pool and appraise the clinical literature
- Defined product standards — sterility, potency, traceable sourcing
- Regulatory clearance for the specific indication, such as partial-thickness burns
- Manufacturing quality — sterile barriers that survive real-world handling
Frequently asked questions
Checklist
Short answers
- Does the review prove honey heals burns? It synthesizes 38 studies reporting benefits — strong encouragement for research, not a prescription for any individual wound.
- Can I put kitchen honey on a burn? No. Table honey is not sterile and its potency is undefined; the research concerns standardized, sterilized medical-grade honey.
- What does “systematic review” mean? A study-of-studies: researchers gather every eligible trial on a question and appraise them against predefined criteria.
- Why does gamma sterilization matter? Burns are highly vulnerable to infection; sterilization per ISO 11137 removes microbial risk while preserving bioactivity.
- How does evidence become a product? Through standards, regulatory clearance (FDA 510(k), product code FRO), manufacturing quality, and market access — the pipeline ghmap.io maps.
If you are bringing a wound-care innovation toward a first market — first clearance, first distributor, first hospital pilot — a ghmap.io country-intelligence brief maps your stages. See the link below.
Next step
Bringing a wound-care product toward a first market? ghmap.io country intelligence maps the regulatory pathway, distribution channels, and reimbursement landscape — country by country. Planning conversations, not approval services and not outcome guarantees.
Get a market-entry brief
